Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

Beijing Hotgen Biotech Revenue

In the year 2025, Beijing Hotgen Biotech had annual revenue of 407.69M CNY, down -20.20%. Beijing Hotgen Biotech had revenue of 97.98M in the quarter ending December 31, 2025, a decrease of -21.45%.

• Revenue: 407.69M
• Revenue Growth: -20.20%
• P/S Ratio: 29.20
• Revenue / Employee: 451.49K
• Employees: 850
• Market Cap: 11.90B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	407.69M	-103.21M	-20.20%
Dec 31, 2024	510.90M	-36.94M	-6.74%
Dec 31, 2023	547.84M	-3.01B	-84.60%
Dec 31, 2022	3.56B	-1.81B	-33.76%
Dec 31, 2021	5.37B	4.86B	945.54%